SAHARA+ Conference on November 24-25, 2023 in Riyadh, Saudi Arabia

SAHARA+ Conference addresses the importance of regulatory frameworks and their role in ensuring patient safety, quality standards, and ethical practices in healthcare as well as explore effective strategies to support the sustainable growth of the healthcare sector in Saudi Arabia. It will provide a platform for healthcare professionals, researchers, and innovators to share their breakthrough discoveries, technological advancements, and novel approaches in addressing healthcare challenges.

The conference will cover six tracks:

Regulatory, Patient Voice and Experience

Insurance and Finance

Private-Public Partnerships

Regulations in Digital Health

Clinical Trials

Real-World Evidence

SAHARA+ Conference will serve as a platform for fruitful discussions on successful strategies and the exchange of best practices, all with the mission of further enhancing healthcare services in Saudi Arabia.

URLs:
Tickets: https://go.evvnt.com/1968108-2?pid=10008

LinkedIn: https://go.evvnt.com/1968108-3?pid=10008

Facebook: https://go.evvnt.com/1968108-4?pid=10008

Twitter: https://go.evvnt.com/1968108-5?pid=10008

Time: 9:00 AM - 5:00 PM

Price:

General Admission: USD 300.00

Speakers: Prof. Ahmed Aljedai Founding President, Saudi Society of Clinical Pharmacy; Professor, Colleges of Medicine and Pharmacy, Alfaisal University; Consultant Clinical Pharmacist, Solid Organ Transplant, Ministry of Health, KSA, Dr. Hajer Al-Mudaiheem Advisor, Assistant Deputy for Therapeutic Supportive Services, Director, Drug Policy and Regulation Department, Ministry of Health, KSA, Dr. Abdulgader Almoeen Health Lead and AI Consultant, National Center for Artificial Intelligence, KSA, Dr. Adel Munshi Doctorate in Pharmaceutical Science, MBA, Bachelor of Law, MOH, KSA, Dr. Mohammed Alshennawi General Director, General Administration of Pharmaceutical Care, MOH, KSA, Dr. Nada Al Agil Policy Design Manager, Consultant Formulary Lead, Project Manager, Council of Cooperative Health Insurance, KSA, Dr. Omaima Arab Ambulatory Care Board, Scientific Evaluation Expert, Saudi Society of Clinical Pharmacy, SFDA, KSA